Welcome to our dedicated page for Oracle SEC filings (Ticker: ORCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Oracle Corporation’s (ORCL) U.S. Securities and Exchange Commission filings, giving investors a primary source of information on the company’s governance, capital structure, and material events. Oracle’s common stock, par value $0.01 per share, is registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ORCL, as disclosed in multiple Forms 8‑K.
Among Oracle’s key filings are current reports on Form 8‑K, which document events such as quarterly financial results, cash dividend declarations, leadership and board changes, and significant financing transactions. Recent 8‑K filings describe press releases announcing fiscal quarter results, the declaration of cash dividends on Oracle’s common stock, the promotion of executives to Chief Executive Officer roles and Principal Financial Officer, the appointment and retirement of directors, and the issuance of senior notes under an existing shelf registration statement.
Oracle’s definitive proxy statement on Schedule 14A (DEF 14A) outlines matters for its annual meeting of stockholders, including the election of directors, an advisory vote on executive compensation, and ratification of its independent registered public accounting firm. The proxy statement also discusses board structure, committees, corporate governance guidelines, stock ownership policies, and executive compensation programs.
Investors may also find Form 25 filings relevant for specific Oracle debt securities. Oracle has filed a Form 25‑NSE relating to the removal from listing of its 3.125% Notes due 2025 from the New York Stock Exchange. This filing concerns a class of notes and is separate from the listing of Oracle’s common stock.
On Stock Titan, Oracle’s SEC filings are organized chronologically and can be paired with AI‑powered summaries that explain the purpose and implications of each document. This helps readers quickly understand items such as 8‑K event descriptions, proxy proposals, and capital markets transactions, while still allowing direct access to the full text of Oracle’s submissions to the SEC.
Clayton M. Magouyrk, listed as President, OCI, reported multiple transactions in Oracle Corporation (ORCL) securities tied to restricted stock unit vesting in September 2025. On 09/19/2025 and 09/20/2025 a total of 129,861 restricted stock units vested and were converted into common stock at no cash price, increasing his beneficial ownership. To pay withholding taxes, on 09/19/2025 16,436 shares were surrendered at $296.62 each and on 09/22/2025 34,665 shares were surrendered at $308.66 each.
After the sequence of vesting and share-withholdings, Magouyrk beneficially owned 194,030 shares of Oracle common stock. The Form 4 was executed by an attorney-in-fact, Aimee Weast, under a power of attorney filed 06/12/2025, and signed on 09/23/2025.
Stuart Levey, Executive Vice President and Chief Legal Officer of Oracle Corporation (ORCL), reported transactions on Form 4 related to the vesting and settlement of restricted stock units (RSUs). On 09/19/2025, 20,884 RSUs vested and were settled into common stock at no cash purchase price, increasing the reported shares acquired by that amount. To satisfy tax withholding on the vesting, 10,244 shares were withheld and disposed of at $296.62 per share. After these transactions the filing shows 38,187 shares beneficially owned (direct) and 62,654 shares beneficially owned when counting derivative securities underlying outstanding RSUs.
Form 144 for ORCL shows a proposed sale of 33,845 common shares through Fidelity Brokerage on the NYSE with an aggregate market value of $10,869,660.20. The filing lists two recent restricted stock vesting events that produced 11,095 and 22,750 shares, acquired as compensation. It also discloses two sales by the same person, Michael Sicilia, totaling 32,203 shares in the past three months with gross proceeds of $9,160,035.20. The filing includes the total shares outstanding of 2,841,714,000. The filer affirms there is no undisclosed material adverse information and that sales are being reported under Rule 144.
Oracle Corporation reported major leadership changes effective September 22, 2025. The Board promoted Clayton Magouyrk and Michael Sicilia to serve as Chief Executive Officers and added both to the Board of Directors. Magouyrk has led Oracle Cloud Infrastructure, while Sicilia has led Oracle’s Industries business, after long tenures in senior roles at the company.
In connection with their promotions, Magouyrk will receive stock options to purchase $250 million in Oracle common stock and Sicilia will receive stock options to purchase $100 million, with 80% in time-based options and 20% in performance-based options that depend on revenue metrics through May 31, 2028, under Oracle’s 2020 Equity Incentive Plan. Safra Catz will step down as Chief Executive Officer and Principal Financial Officer and become Executive Vice Chair of the Board, while Douglas Kehring has been named Executive Vice President and Principal Financial Officer.
Maria Smith, EVP and Chief Accounting Officer of Oracle Corporation (ORCL), reported equity activity on Form 4 dated 09/17/2025 covering transactions on 09/15/2025. She received 13,169 restricted stock units (RSUs) that vested (reported as acquisition at $0) and 6,862 shares were disposed at a price of $292.18 per share, with 55,592 shares before and 48,730 shares after the sale. The filing explains 6,862 shares were withheld to cover tax liability upon vesting and that RSUs vest in four equal annual installments beginning on the first anniversary of grant. The Form 4 was signed by an attorney-in-fact under a POA.
Insider transactions by Michael D. Sicilia at Oracle Corporation (ORCL) show settlement of restricted stock units and subsequent open-market sales in mid-September 2025. On 09/15/2025 Mr. Sicilia was credited with 52,673 RSUs that vested and 25,468 shares were disposed to cover taxes at $292.18 per share, leaving 126,417.279 shares. On 09/16/2025 he sold 16,323 shares at $313.60, leaving 110,094.279 shares. An additional 2,655 shares are indirectly owned by spouse. The filing indicates a 10b5-1 plan/covered transaction and was signed by a power of attorney.
Stuart Levey, EVP and Chief Legal Officer of Oracle Corporation (ORCL), reported multiple transactions on 09/15/2025. He was granted 26,337 restricted stock units (RSUs) that represent the right to receive one share each at settlement, increasing his RSU holdings to 52,674 underlying shares after the grant. On the same date he disclosed the disposition of 12,405 shares in an open-market sale at an average price of $292.18, leaving him with 27,547 shares owned directly. The RSUs vest in four equal annual installments beginning one year after grant. Shares were withheld to satisfy tax withholding upon vesting as noted in the filing. The form was signed by a power of attorney on behalf of Mr. Levey.
Jeffrey Henley, Vice Chairman and Director at Oracle Corp (ORCL), reported routine insider transactions on Form 4 dated 09/15/2025. He acquired 19,753 shares through the vesting of restricted stock units at no cash price and had 8,629 shares disposed of at $292.18 per share (shares withheld to cover tax obligations). After the transactions, Henley beneficially owned 984,363 shares indirectly (held by trust and other vehicles including a GRAT and Henley Community Property Trust).
William G. Parrett, a director of Oracle Corporation (ORCL), reported a non-derivative transaction on 09/12/2025. The filing shows a sale of 11,500 shares of Oracle common stock at a reported price of $306 per share. Following the reported transactions, the form lists 17,764 shares held indirectly (by trust) and 9,311 shares held directly as the amounts beneficially owned after the transactions.
Clayton M. Magouyrk, an officer of Oracle Corporation (ORCL), reported several transactions in mid-September 2025. On 09/12/2025 he sold 21,241 shares at $297.1077, reducing his direct holdings to 78,000 shares. On 09/15/2025 he was granted 61,452 restricted stock units (RSUs) that represent the right to receive one share each at settlement; those RSUs vest in four equal annual installments beginning one year after grant. The same day shows a disposition of 24,182 shares at $292.18, leaving 115,270 shares held directly after the reported transactions. Following the RSU grant, he beneficially owns 122,905 derivative shares related to outstanding RSUs.